Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons

Rodger David MacArthur, G. Peng, R. M. Novak, M. van den Berg-Wolf, M. Kozal, L. Besch, T. Yurik, B. Schmetter, C. Henley, M. Dehlinger

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons'. Together they form a unique fingerprint.

Medicine & Life Sciences